BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction

Reuters03-11

BRIEF-Vistagen <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Implements 20% Workforce Reduction

March 11 (Reuters) - VistaGen Therapeutics Inc VTGN.O:

VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILING
VISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILING
VISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILING
VISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILING
VISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILING

Source text: [ID:n0001628280-26-016652]

Further company coverage: VTGN.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2618949224?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 19:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618949224","market":"fut","top_or_hot":-1,"title":"BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Vistagen <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Implements 20% Workforce Reduction</title></head><body><p><span>March 11 (Reuters)</span><span> - </span>VistaGen Therapeutics Inc <span>VTGN.O</span>:</p><ul><li><p>VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILING</p></li></ul><p>Source text: [ID:n0001628280-26-016652]</p><p>Further company coverage: <span>VTGN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-11 19:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Vistagen <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Implements 20% Workforce Reduction</title></head><body><p><span>March 11 (Reuters)</span><span> - </span>VistaGen Therapeutics Inc <span>VTGN.O</span>:</p><ul><li><p>VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILING</p></li><li><p>VISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILING</p></li></ul><p>Source text: [ID:n0001628280-26-016652]</p><p>Further company coverage: <span>VTGN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ0FD:1","article_id":"2618949224","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618949224","pubTimestamp":1773227656,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Vistagen Therapeutics Implements 20% Workforce ReductionMarch 11  - VistaGen Therapeutics Inc VTGN.O:VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILINGVISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILINGVISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILINGSource text: [ID:n0001628280-26-016652]Further company coverage: VTGN.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","VTGN":"VistaGen Therapeutics, Inc."},"translate_title":"简介-Vistagen Therapeutics实施裁员20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTGN":0.9},"content_text":"BRIEF-Vistagen Therapeutics Implements 20% Workforce ReductionMarch 11 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILINGVISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILINGVISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILINGSource text: [ID:n0001628280-26-016652]Further company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618949224","isCrawlerRequest":true}